Linking Biotechnologies for Human Healthcare
Recent projects of Biolink International, Inc.
Business Dev. & Business Assessment
  • Antibacterial Topical (Line-extension negotiation)
  • Cardiovascular/Sepsis (Partner's clinical & regulatory activities)
  • CNS/Dementia(Business assessment report)
  • Cerebro-vascular disease (Market analysis report)
  • Cancer/Mucositis (Report for territory option decision)
  • Cancer support/CINV (Business assessment report)
  • Immuno cell therapy/Cancer (Business assessment report)
  • Enzyme replacement therapy/pancreatitis (Market analysis report)
  • Chronic anal fissure (Market entry assessment report)
  • Endometriosis (Market analysis report)
Licensing to Japan
  • Synthetic Bone material
  • Renal disorders
  • Cancer (MAbs)
  • Cancer support therapy
  • Movement disorder
  • Dementia
  • Other technology licenses
Licensing from Japan
  • Urinary & Hormones
  • Eye care drug candidates
  • Glioma (MAb)
  • Cancer
  • Infection
Novel Seed Pharmaceuticals
  • Fusion protein therapeutics for cancer treatment
Drug Discovery Tools
  • Proteomics drug discovery platform for 'Fee for Service' operations in Japan
  • Data driven drug design technology for generation of lead pharmaceuticals for pharmaceutical firms
c 2011 Biolink International, Inc.
No portion of this site may be reproduced without the express written permission of Biolink International, Inc. All rights reserved